Li, Zhi
First Hospital of China Medical University · China Medical University
4 papers on CoChatORCID 0000-0002-6437-0348
Most cited papers
- Verified
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell
Renal cell carcinoma treatmentCancer Genomics and Diagnostics
Cited by 730
- Verified
Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
Zhang, C., Fan, Y., Che, X., Zhang, M., Li, Z., Li, C., Wang, S., Wen, T., Hou, K., Shao, X., et al. (2020) · Frontiers in Oncology
Cancer Immunotherapy and BiomarkersExtracellular vesicles in disease
Cited by 69
- Verified
Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR
Palijan, A., Fernandes, I., Bastien, Y., Tang, L., Verway, M., Kourelis, M., Tavera-Mendoza, L. E., Li, Z., Bourdeau, V., Mader, S., et al. (2009) · Journal of Biological Chemistry
Histone Deacetylase Inhibitors ResearchEstrogen and related hormone effects
Cited by 65
- Verified
Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction
Wu, Y., Wang, K.-Y., Li, Z., Liu, Y.-P., Izumi, H., Uramoto, H., Nakayama, Y., Ito, K.-I., & Kohno, K. (2014) · Journal of Experimental & Clinical Cancer Research
Cancer therapeutics and mechanismsBioactive Compounds and Antitumor Agents
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free